Faculty profile

Marie Hudson

ResearcherPsychiatryMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Marie Hudson

Researcher

Psychiatry

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
92 publications in the last five years, latest in 2026.
Senior (last) author on 16 recent papers, a sign of leading a research group.
Principal investigator on 7 research grants (7 CIHR), most recently in 2023.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

324

Publications

3,457

Citations

138

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Systemic Sclerosis Rheumatoid Arthritis Systemic Lupus Erythematosus 1000minds Classification Criteria Multicriteria Decision Analysis Scleroderma Renal Crisis Mesenchymal Stem Cells

Latest papers

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?
Arthritis Care and Research · 2026
Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies
Rheumatology · 2026
Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry.
Rheumatology (Oxford, England) · 2026

All 324 publications

Latest funding

Course and predictors of patient-reported outcomes from systemic sclerosis onset: A Scleroderma Patient-centered Intervention Network Cohort longitudinal study and individual participant data meta-analysis
CIHR · 2025 · Co-investigator
$967,726
Examining the role of the JAK-STAT pathway in ICI-arthritis and the effects of JAK inhibition on ICI in a novel tumor model of ICI-arthritis
CIHR · 2025 · Supervisor
$120,000
Pre-clinical development of a peptide biologic for the treatment of idiopathic and scleroderma-related lung fibrosis
CIHR · 2025 · Co-investigator
$631,125

All 27 grants and awards

From the 150 most recent of 324 publications.

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

Goulet D, Guertin C, Larché M, Ferdinand I, Hudson M, Choi MY, Osman M, Pope J, Thorne C, Baron M

Arthritis Care and Research20261 citations

DOI: 10.1002/acr.80098

Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies

Barreth N, Leclair V, Hudson M, Bernatsky S, Krustev E, Toro CM, St Pierre Y, Clarke A, Sciore PJA, Tarnopolsky M

Rheumatology2026

DOI: 10.1093/rheumatology/keag139

Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry.

Shen HC, Leclair V, Cotton T, Troyanov Y, Hudson M, Gyger G

Rheumatology (Oxford, England)2026

DOI: 10.1093/rheumatology/keag188 PMID: 41968831

Mouse models of immune-related adverse events: progress, challenges, and opportunities.

Papadopoulos T, Pinto A, Abraham MJ, Naranjo CL, Molina MF, Hudson M, Miller WH, Del Rincón SV

Trends in cancer2026

DOI: 10.1016/j.trecan.2026.04.010 PMID: 42161754

Does the ACR/EULAR Total Improvement Score Reflect How Individuals With Autoimmune Inflammatory Myopathies Feel and Function?

Leclair V, Berger C, Bouchard-Marmen M, Bourré-Tessier J, Landon-Cardinal O, Canadian Inflammatory Myopathy Study, Hudson M

The Journal of rheumatology2026

DOI: 10.3899/jrheum.2026-0046 PMID: 42297433

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Harvey GR, Ashur I, Bossuyt X, Bluethner M, Brusch A, Bundell C, Chinoy H, Coeshott C, Choi MY, Donald C, Dunphy J, Fritzler MJ, Heaps A, Hudson M, Kuwana M, Landon-Cardinal O, Lu H, McMorrow F, Mayrhofer M, Meyer A, Michiels B, Nespola B, O'Loughlin S, Putova I, Sadler R, Sanz-Martinez MT, Sciore P, Selva-O'Callaghan A, Storfors H, Trallero-Araguás E, Troyanov Y, Tyson J, Vencovský J, Vinas-Giménez L, Yoshida A, Rönnelid J, McHugh NJ, Tansley S, IMACS

Journal of autoimmunity2026

DOI: 10.1016/j.jaut.2026.103548 PMID: 41863861

Getting It Right for Our Patients.

Hudson M, Solomon DH

Arthritis & rheumatology (Hoboken, N.J.)2026First author

DOI: 10.1002/art.70049 PMID: 41480734

Tolerability and Safety of Nintedanib and Immunosuppression in Autoimmune Inflammatory Myopathy-Associated Progressive Pulmonary Fibrosis.

Assayag D, Brilland B, Hudson M, Azuelos I, Langlais D, Hirsch A

CHEST pulmonary2026

DOI: 10.1016/j.chpulm.2025.100230 PMID: 42548349

Digital [18F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis.

Abikhzer G, Roy A, Samson M, Dendukuri N, Makhzoum JP, Stein MA, Hudson M, Rousseau É, Nienhuis PH, Van der Geest KSM, Pineau C, Liang P, Levin LA, Slart RHJA, Alberini JL

European journal of nuclear medicine and molecular imaging2026

DOI: 10.1007/s00259-026-08131-7 PMID: 42625054

Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets.

Leclair V, Cotton T, Shen HC, Berger C, Troyanov Y, Hudson M, Gyger G, Canadian Inflammatory Myopathy Study

Rheumatology (Oxford, England)2026

DOI: 10.1093/rheumatology/keaf594 PMID: 41206056

Something wrong or missing on this profile? Suggest a correction

Marie Hudson

Research

Latest papers

Latest funding

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies

Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry.

Mouse models of immune-related adverse events: progress, challenges, and opportunities.

Does the ACR/EULAR Total Improvement Score Reflect How Individuals With Autoimmune Inflammatory Myopathies Feel and Function?

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Getting It Right for Our Patients.

Tolerability and Safety of Nintedanib and Immunosuppression in Autoimmune Inflammatory Myopathy-Associated Progressive Pulmonary Fibrosis.

Digital [18F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis.

Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets.

Frequent collaborators

Murray Baron

Nader Khalidi

Sasha Bernatsky

Russell Steele

Sasha Bernatsky

Margaret Larche

Sabrina Hoa

Sabrina Hoa

Janet Pope

Andrea Benedetti

Linda Kwakkenbos

Samy Suissa

Ines Colmegna

Andrea Benedetti

Nancy Maltez

Carrie Ye

Danielle Rice

Elham Rahme

Mark Harrison

Louise Pilote

Louise Pilote

Jason Karamchandani

Jason Karamchandani

Ian Shrier

Tomi Pastinen

Lawrence Joseph

Dan Bilsker

Mark Tarnopolsky

Mark Matsos

Faiza Khokhar

J Michael Paterson

Robert Rottapel

Stephanie Keeling

Tomoko Takano

Brett Thombs

Deborah Da Costa

Michal Abrahamowicz

Christel Renoux

Gerald Batist

Wilson Miller